Stem cell treatment for age-related muscle loss
Part of Brain & nervous system clinical trials.
This study tests an experimental treatment called EN001, made from stem cells, to see if it can help improve muscle strength and function in older adults with sarcopenia. Participants will receive the treatment or a placebo, and all will follow a diet and exercise program.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 60 years old or older.
- You must have a confirmed diagnosis of sarcopenia (age-related muscle loss) with low muscle strength, slow walking speed, and low muscle mass.
- You must be able to follow a diet and exercise plan for at least 4 weeks before starting the treatment.
- Your blood work must meet certain safety levels (like hemoglobin, white blood cells, and liver function).
- You must not have serious heart, kidney, or liver disease, uncontrolled diabetes or high blood pressure, or a history of cancer in the last 5 years (except some skin cancers).
- You must not have used certain medications or treatments (like testosterone, growth hormones, or prior cell or gene therapy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called AMC6156 to see if it can help improve muscle mass and strength in older adults with sarcopenia (age-related muscle loss). Participants will also follow exercise and nutrition guidance.
This trial tests a combined exercise and nutrition program to help older adults with sarcopenia (muscle loss). It aims to improve muscle strength and function, especially for those with metabolic syndrome.
This trial tests an injection of donor bone marrow stem cells to see if it can improve muscle strength and function in people with age-related muscle loss, called sarcopenia. It may help those who cannot do regular exercise training.
This trial tests whether a muscle-stimulation device (using mild electrical pulses) can help people with sarcopenia (age-related muscle loss) regain strength. You'll also do an exercise program, and the study aims to see if this combination improves mobility and function.
This trial tests a new approach to treat sarcopenia (age-related muscle loss) by targeting a protein called HIF-1α. It compares older adults with sarcopenia to younger adults without it, all of whom are having hip or knee surgery.
This study tests if a combination of a medicine (nandrolone), physical therapy, and a special diet can help older adults with muscle loss (sarcopenia) improve their strength and muscle mass. It is for people age 60 to 99 who have been diagnosed with sarcopenia based on specific muscle strength and mass measurements.
Hear when a new Sarcopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.